Gascón, M., Isla, D., Cruellas, M., Gálvez, E. M., Lastra, R., Ocáriz, M., . . . Martínez-Lostao, L. (2020). Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One? MDPI AG.
Chicago Style (17th ed.) CitationGascón, Marta, et al. Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One? MDPI AG, 2020.
MLA (9th ed.) CitationGascón, Marta, et al. Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One? MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.